Drug therapy overview

An integrated approach of health maintenance (e.g., smoking cessation), drug therapy, and supplemental therapy (e.g., oxygen and pulmonary rehabilitation) should be used in a stepwise manner. Table 12-2 provides an overview of the management of stable COPD. 

Kales, A. (1991). An overview of safety problems of triazolam. International Drug Therapy Newsletter, 26(7), 25-28. 

Before analyzing the interrelated systems of pharmaceutical care, a brief overview of this new professional practice will be helpful. The landmark pharmaceutical care article published in 1990 creafed the theoretical constructs for the responsible provision of drug therapy. This article set the foundation for the development of a new professional practice. Through efforts aimed at moving from theory into application, the definition of fhis new professional practice emerged. A pharmaceutical care practice then is defined as a practice in which the practitioner takes responsibility for all of a patient s drug-related needs and is held accountable for this commitment. ... 

Michael, M. Doherty, M. M. Tumoral drug metabolism overview and its implications for cancer therapy J. Qin. Oncol. 2005, 23, 205-229. 

Pharmacoeconomics. URL http //www.dimdee.ac.uk/memo/ memoonly/PHECOO.HTM (accessed October 2005). The aim of this tutorial is to provide an overview of pharmacoeconomics and to show how it can be applied practically to decisions about drug therapy. 

Overview of Drug Therapy Affecting The Renin-Angiotensin Pathway... 

Saltzman WM (2001) Overview of polymeric materials. In Saltzman WM (ed) Drug Delivery - Engineering principles for drug therapy. Oxford University Press, New York, chap Appendix A, p 320... 

Aapro MS 5-HT3 receptor antagonists an overview of their present status and future potential in cancer therapy-induced emesis. Drugs 42 551-568, 1991... 

Rosecrans JA, Chance WT (1978) The discriminative stimulus properties of n- and m-cholinergic receptor stimulants. In Ho BT, Richards DW III, Chute DL (eds) Drug discrimination and state dependent learning. Academic, New York, pp 119-130 Rosecrans JA, Schechter MD (1972) Brain area nicotine levels in male and female rats of two strains. Arch Int de Pharmacodynamic et de Therapie 196 46-54 Rosecrans JA, Kallman MJ, Glennon RA (1978) The nicotine cue an overview. In Colpaert EC, Rosecrans JA (eds) Stimulus properties of drugs ten years of progress. Elsevier-North Holland, Amsterdam, pp 69-81... 

Verheul R, van den Brink W Hartgers C (1995). Prevalence of personality disorders among alcoholics and drug addicts an overview. European Addiction Research, 1, 166-77 Vignau J Brunelle E (1998). Differences between general practitioner- and addiction centre-prescribed buprenorphine substitution therapy in France. Preliminary results. European Addiction Research, 4, suppl 1, 24-8 Vocci FJ Appel NM (2007). Approaches to the development of medications for the... 

When cancer is diagnosed, three primary treatment modalities are available surgery, radiation treatment, and cancer chemotherapy. The purpose of this chapter is to describe the basic rationale of cancer chemotherapy and to provide an overview of the drugs that are currently available to treat specific forms of cancer. Rehabilitation specialists will routinely work with patients undergoing cancer chemotherapy. For reasons that will become apparent in this chapter, these drugs tend to produce toxic effects that directly influence physical therapy and occupational therapy procedures. Therefore, this chapter should provide therapists with a better understanding of the pharmacodynamic principles and beneficial effects, as well as the reasons for the potential adverse effects of these important drugs. 

The book is comprised of five sections with part I covering systemic and endoluminal therapy with an incisive overview of hemostasis and thrombosis part II covers local therapy with several chapters devoted to drug-eluting stents and restenosis therapies part III covers cell therapy and therapeutic angiogenesis and includes chapters on cell transplantation and clinical trials in cellular therapy part IV covers adjunctive pharmacotherapy with chapters devoted to various patient populations including those with heart failure, diabetes, atrial fibrillation, peripheral artery disease,... 

---